Matthew S. Yorek

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice

Samuel A.J. Trammell, Benjamin J. Weidemann, Ankita Chadda et al. · Scientific Reports · 2016 · 302 citations · Full text

Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243

Laura M. Dutca, Steven F. Stasheff, Adam Hedberg‐Buenz et al. · Investigative Ophthalmology & Visual Science · 2014 · 88 citations · Full text

Nociceptive sensitization by complement C5a and C3a in mouse

Jun Ho Jang, David J. Clark, Xiangqi Li et al. · Pain · 2009 · 86 citations · Full text

Acute Pain, Pain Medicine, Immunology +18

Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes

Hanna Shevalye, Matthew S. Yorek, Lawrence J. Coppey et al. · Journal of Neurophysiology · 2015 · 81 citations · Full text

Nutrition, Polyphenolics, Oxidative Stress +17

Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction.

Stephaine L Cincotta, Matthew S. Yorek, Travis M. Moschak et al. · PubMed · 2008 · 72 citations

Potential Therapies, Neuropsychology, Neuropsychiatric Disorders +17